Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
Certara (Nasdaq: CERT) announced it will release its second quarter 2026 financial results before the market opens on Tuesday, August 4, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Certara (Nasdaq: CERT) announced it will release its second quarter 2026 financial results before the market opens on Tuesday, August 4, 2026. Company management will hold a conference call at 8:30 AM ET, with live and archived webcast access via the Investors section of Certara’s website.
Details
Market move: CERT +3.12% in the Jul 16 session. 2Q26 earnings report date
On Jul 16, the first trading day after this news, CERT closed 3.12% above the previous close. Our momentum scanner recorded 3 alerts for this stock that day.
Data tracked by StockTitan Argus for the Jul 16 session.
Key Figures
- Reporting period
- second quarter of 2026
- Upcoming earnings release
- Earnings release date
- August 4, 2026
- 2Q26 results to be released before market open
- Conference call time
- 8:30 AM ET
- Management call to discuss 2Q26 results
Previous Earnings date Reports
-
Set timing for Q1 2026 results and accompanying investor call.
-
Announced Q4 and full-year 2025 results release schedule and call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., July 15, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2026 before market open on Tuesday, August 4th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
About Certara
Certara transforms drug discovery and development for good, helping scientists and clinical teams generate regulatory-grade evidence faster. Its solutions combine biosimulation, clinical intelligence, and regulatory science, and are embedded in the workflows of drug developers worldwide. Certara clients include more than 2,600 biopharmaceutical companies, academic institutions, and global regulatory agencies. Learn more at certara.com.
Investor Relations Contact:
Erik Abdow
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.